JP2022512646A5 - - Google Patents
Info
- Publication number
- JP2022512646A5 JP2022512646A5 JP2021519609A JP2021519609A JP2022512646A5 JP 2022512646 A5 JP2022512646 A5 JP 2022512646A5 JP 2021519609 A JP2021519609 A JP 2021519609A JP 2021519609 A JP2021519609 A JP 2021519609A JP 2022512646 A5 JP2022512646 A5 JP 2022512646A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antibody
- antigen
- nos
- binding fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862743501P | 2018-10-09 | 2018-10-09 | |
| US62/743,501 | 2018-10-09 | ||
| PCT/US2019/055144 WO2020076790A1 (en) | 2018-10-09 | 2019-10-08 | Antibodies directed against staphylococcus aureus leukotoxins |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022512646A JP2022512646A (ja) | 2022-02-07 |
| JP2022512646A5 true JP2022512646A5 (cg-RX-API-DMAC7.html) | 2022-10-18 |
| JP7459075B2 JP7459075B2 (ja) | 2024-04-01 |
Family
ID=68393067
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021519609A Active JP7459075B2 (ja) | 2018-10-09 | 2019-10-08 | スタフィロコッカス・アウレウス(Staphylococcus aureus)ロイコトキシンに対して向けられた抗体 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US11059884B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3864040A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7459075B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102960761B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN113015745B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2019359207B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112021006704A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3115765A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2021004114A (cg-RX-API-DMAC7.html) |
| TW (1) | TWI895248B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020076790A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2917360B1 (en) * | 2012-11-06 | 2020-01-08 | Medlmmune, LLC | Antibodies to s. aureus surface determinants |
| MX2021000889A (es) | 2018-07-24 | 2021-04-28 | Medimmune Llc | Anticuerpo dirigido contra el factor de agregación a (clfa) de s. aureus. |
| WO2020076790A1 (en) | 2018-10-09 | 2020-04-16 | Medimmune, Llc | Antibodies directed against staphylococcus aureus leukotoxins |
| MX2021004173A (es) | 2018-10-09 | 2021-09-08 | Medimmune Llc | Combinaciones de anticuerpos dirigidos contra staphylococcus aureus. |
| JP7682795B2 (ja) | 2019-03-13 | 2025-05-26 | メディミューン,エルエルシー | コロニー形成患者における黄色ブドウ球菌(Staphylococcus aureus)感染症の低減 |
| CN113493510A (zh) * | 2021-07-07 | 2021-10-12 | 上海交通大学 | 一种牛源抗金黄色葡萄球菌LukD毒力因子的单链抗体及其制备和应用 |
| CN113583119B (zh) * | 2021-07-07 | 2023-05-02 | 西北农林科技大学 | 抗金黄色葡萄球菌的纳米抗体Nb56、应用及试剂盒 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7658921B2 (en) | 2000-12-12 | 2010-02-09 | Medimmune, Llc | Molecules with extended half-lives, compositions and uses thereof |
| AU2002368077B2 (en) | 2001-07-12 | 2010-03-04 | Jefferson Foote | Super humanized antibodies |
| US20040014194A1 (en) | 2002-03-27 | 2004-01-22 | Schering Corporation | Beta-secretase crystals and methods for preparing and using the same |
| JP5675109B2 (ja) | 2007-02-20 | 2015-02-25 | アナプティスバイオ インコーポレイティッド | ライブラリーの生成方法及びその使用 |
| CN102387814A (zh) | 2009-01-29 | 2012-03-21 | 米迪缪尼有限公司 | 延长体内半衰期的人抗il-6抗体及其在治疗肿瘤、自身免疫性疾病和炎症性疾病中的应用 |
| LT3444268T (lt) * | 2010-05-05 | 2022-04-11 | New York University | Staphylococcus aureus leukocidinai, terapinės kompozicijos ir jų panaudojimo būdai |
| RS58190B2 (sr) | 2011-02-08 | 2021-08-31 | Medimmune Llc | Antitela koja specifično vezuju staphylococcus aureus alfa toksin i postupci njihove primene |
| EP2917360B1 (en) | 2012-11-06 | 2020-01-08 | Medlmmune, LLC | Antibodies to s. aureus surface determinants |
| ES2912267T3 (es) | 2012-11-06 | 2022-05-25 | Medimmune Llc | Métodos de tratamiento de enfermedades asociadas a S. aureus |
| CN105873946A (zh) * | 2013-10-17 | 2016-08-17 | 阿尔萨尼斯生物科学有限责任公司 | 交叉反应性金黄色葡萄球菌抗体序列 |
| JP6832709B2 (ja) | 2014-05-16 | 2021-02-24 | メディミューン,エルエルシー | 新生児Fc受容体結合が改変されて治療および診断特性が強化された分子 |
| TWI719938B (zh) | 2014-06-19 | 2021-03-01 | 美商麥迪紐有限責任公司 | 多重細菌感染之治療 |
| AU2016249837A1 (en) | 2015-04-17 | 2017-09-28 | Arsanis Biosciences Gmbh | Anti-staphylococcus aureus antibody combination preparation |
| US20190077851A1 (en) | 2015-10-30 | 2019-03-14 | Bruno Francois | Methods of using anti-alpha toxin antibody |
| MX2021000889A (es) | 2018-07-24 | 2021-04-28 | Medimmune Llc | Anticuerpo dirigido contra el factor de agregación a (clfa) de s. aureus. |
| MX2021004173A (es) * | 2018-10-09 | 2021-09-08 | Medimmune Llc | Combinaciones de anticuerpos dirigidos contra staphylococcus aureus. |
| WO2020076790A1 (en) | 2018-10-09 | 2020-04-16 | Medimmune, Llc | Antibodies directed against staphylococcus aureus leukotoxins |
-
2019
- 2019-10-08 WO PCT/US2019/055144 patent/WO2020076790A1/en not_active Ceased
- 2019-10-08 AU AU2019359207A patent/AU2019359207B2/en active Active
- 2019-10-08 KR KR1020217013374A patent/KR102960761B1/ko active Active
- 2019-10-08 US US16/596,445 patent/US11059884B2/en active Active
- 2019-10-08 EP EP19795711.1A patent/EP3864040A1/en active Pending
- 2019-10-08 CN CN201980074188.5A patent/CN113015745B/zh active Active
- 2019-10-08 JP JP2021519609A patent/JP7459075B2/ja active Active
- 2019-10-08 MX MX2021004114A patent/MX2021004114A/es unknown
- 2019-10-08 CA CA3115765A patent/CA3115765A1/en active Pending
- 2019-10-08 TW TW108136342A patent/TWI895248B/zh active
- 2019-10-08 BR BR112021006704-3A patent/BR112021006704A2/pt unknown
-
2021
- 2021-06-07 US US17/340,622 patent/US11578119B2/en active Active